This antibody recognises secretory leukocyte protease inhibitor (SLPI), a ~14 kDa non-glycosylated protein produced by secretory cells in the respiratory, genital and lachrymal glands, and by macrophages, B-cells and neutrophils.The functions of SLPI are diverse. The SLPI protein inhibits protease activity at sites of inflammation, protecting tissues against protease mediated damage and it possesses anti-microbial/anti-viral activity. In addition, SLPI has been reported to exhibit anti-inflammatory properties, regulating lipopolysaccharide induced activation of NF-kappa beta in peripheral blood monocytes.
Applications
WB, IHC-P
Dilutions
WB: 1.0 - 2 µg/ml
Reactivity
Human, Mouse
Immunogen
A peptide corresponding to 17 amino acids near the centre of human SLPI.
Host
Rabbit
Clonality
Polyclonal
Isotype
IgG
Conjugate
Unconjugated
Concentration
1 mg/ml
Molecular Weight
Approximately 14 kDa in Daudi cell lysates.
Product Form
Liquid
Formulation
Supplied in Phosphate Buffered Saline with 0.02% Sodium Azide.
Storage
Shipped at ambient temperature. Upon delivery aliquot and store at -20°C. When thawed, aliquot the sample as needed. Short term (up to 4 weeks): store at 4°C. Long term: store at -20°C. Avoid freeze / thaw cycles. Storage in frost free freezers is not recommended.
General Notes
Rabbit anti Human SLPI antibody recognizes secretory leukocyte protease inhibitor (SLPI), a ~14 kDa non-glycosylated protein produced by secretory cells in the respiratory, genital and lachrymal glands, and by macrophages, B-cells and neutrophils. The functions of SLPI are diverse. The SLPI protein inhibits protease activity at sites of inflammation, protecting tissues against protease mediated damage and it possesses anti-microbial/anti-viral activity. In addition, SLPI has been reported to exhibit anti-inflammatory properties, regulating lipopolysaccharide induced activation of NF-kappa beta in peripheral blood monocytes.
